Campylobacter jejuni IgA Control Serum BC139A

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Campylobacter jejuni IgA Control Serum
Applications: ELISA
IgA control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC139A Categories: control serum, Virion/Serion kits Tags: Campylobacter jejuni, ELISA control serum, IgA

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Campylobacter jejuni reactive IgA
species reactivity	Campylobacter jejuni
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Campylobacter jejuni IgA Control Serum BC139A

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Campylobacter jejuni Antigen (BA139VS) Campylobacter jejuni IgA Control Serum (BC139A) Campylobacter jejuni IgG Control Serum (BC139G) Campylobacter jejuni IgM Control Serum (BC139M) Campylobacter jejuni IgA ELISA Kit (ESR139A) Campylobacter jejuni IgG ELISA Kit (ESR139G) Campylobacter jejuni IgM ELISA Kit (ESR139M)

target relevance

human antibody anti-Campylobacter jejuni

Campylobacter jejuni

Description
Bacterium that causes campylobacteriosis and bacterial gastroenteritis

Structure
Campylobacter jejuni is a Gram-negative, microaerophilic, curved or spiral-shaped bacterium belonging to the family Campylobacteraceae. The organism possesses one or more polar flagella that provide characteristic corkscrew-like motility, enabling movement through intestinal mucus and facilitating colonization of the gastrointestinal tract. C. jejuni is widely distributed among domestic and wild animals, particularly poultry, which serve as major reservoirs of human infection. The bacterium is one of the leading causes of bacterial gastroenteritis worldwide and is commonly transmitted through consumption of undercooked poultry, unpasteurized milk, contaminated water, or direct contact with infected animals. Campylobacter jejuni possesses numerous virulence factors that promote adherence, invasion, toxin production, and immune evasion, contributing to intestinal inflammation and disease.

Diagnosis
The diagnosis of Campylobacter jejuni infection is performed through microbiological, molecular, and antigen detection methods. Isolation of the organism from stool specimens using selective culture media under microaerophilic conditions remains a standard diagnostic approach. Polymerase chain reaction (PCR) assays provide rapid and highly sensitive detection of Campylobacter DNA and are increasingly included in multiplex gastrointestinal pathogen panels. Antigen detection assays may also be used in some clinical laboratories. Laboratory findings are often nonspecific but may include elevated inflammatory markers and fecal leukocytes. Accurate diagnosis is important because the clinical presentation can resemble infections caused by Salmonella, Shigella, pathogenic Escherichia coli, and other enteric pathogens.

Symptoms
Campylobacter jejuni infection typically develops following an incubation period of approximately two to five days after exposure. Clinical manifestations commonly include diarrhea, which may become bloody, abdominal cramping, fever, nausea, vomiting, headache, and malaise. The abdominal pain may be severe enough to mimic acute appendicitis. Most infections are self-limiting and resolve within several days to one week; however, severe disease may occur in young children, elderly individuals, and immunocompromised patients. Important post-infectious complications include reactive arthritis, irritable bowel syndrome, and Guillain-Barré syndrome, an autoimmune neurological disorder that can result in progressive muscle weakness and paralysis. In rare cases, bloodstream infection and other invasive complications may occur.

Data

FAQ & Publications

Frequently Asked Questions

What applications is the Campylobacter jejuni IgA Control Serum BC139A suitable for?

The Campylobacter jejuni IgA Control Serum BC139A is designed for use as an IgA control serum in ELISA assays, specifically compatible with SERION ELISA classic and SERION ELISA antigen assays.

How should the Campylobacter jejuni IgA Control Serum BC139A be stored to maintain its stability?

The serum should be stored at 2-8°C to preserve its stability and ensure optimal performance in assays.

Is the Campylobacter jejuni IgA Control Serum BC139A reactive with other species or specific to Campylobacter jejuni?

This control serum is specific and reactive to Campylobacter jejuni IgA antibodies, making it suitable for studies targeting this bacterial species.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC139A protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Campylobacter jejuni IgA Control Serum BC139A

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Campylobacter jejuni IgG ELISA Kit MD-6204

Brucella IgA Control Serum BC116A

Mycoplasma pneumoniae IgA Control Serum BC127A

Bordetella pertussis IgA Control Serum BC120A

Helicobacter pylori IgA Control Serum BC118A

Adenovirus IgA Control Serum BC128A

Enterovirus IgA Control Serum BC133A

Campylobacter jejuni IgA ELISA Kit MD-6205

Echovirus IgA Control Serum BC135A

Coxsackie IgA Virus Control Serum BC134A

Chlamydia trachomatis IgA Control Serum BC1372A

Chlamydia pneumoniae IgA Control Serum BC1371A

Candida albicans IgA Control Serum BC117A

Campylobacter jejuni IgG Control Serum BC139G

Campylobacter jejuni IgM Control Serum BC139M